Cargando…
Use of the Common Marmoset to Study Burkholderia mallei Infection
Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, an...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393281/ https://www.ncbi.nlm.nih.gov/pubmed/25860021 http://dx.doi.org/10.1371/journal.pone.0124181 |
_version_ | 1782366142011015168 |
---|---|
author | Jelesijevic, Tomislav Zimmerman, Shawn M. Harvey, Stephen B. Mead, Daniel G. Shaffer, Teresa L. Estes, D. Mark Michel, Frank Quinn, Frederick D. Hogan, Robert J. Lafontaine, Eric R. |
author_facet | Jelesijevic, Tomislav Zimmerman, Shawn M. Harvey, Stephen B. Mead, Daniel G. Shaffer, Teresa L. Estes, D. Mark Michel, Frank Quinn, Frederick D. Hogan, Robert J. Lafontaine, Eric R. |
author_sort | Jelesijevic, Tomislav |
collection | PubMed |
description | Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, and the most common manifestations are life-threatening pneumonia and bacteremia. Glanders is difficult to diagnose and requires prolonged antibiotic therapy with low success rates. There is no vaccine to protect against B. mallei and there is concern regarding its use as a biothreat agent. Thus, experiments were performed to establish a non-human primate model of intranasal infection to study the organism and develop countermeasures. Groups of marmosets (Callithrix jacchus) were inoculated intranasally with B. mallei strain ATCC 23344 and monitored for clinical signs of illness for up to 13 days. We discovered that 83% of marmosets inoculated with doses of 2.5 X 10(4) to 2.5 X 10(5) bacteria developed acute lethal infection within 3–4 days. Signs of disease were severe and included lethargy, inappetence, conjunctivitis, mucopurulent and hemorrhagic nasal discharges, and increased respiratory effort with abdominal lifts. Burkholderia mallei was cultured from the lungs, spleen and liver of these animals, and pathologic examination of tissues revealed lesions characteristic of glanders. Challenge experiments also revealed that 91% of animals infected with doses ranging from 25 to 2.5 X 10(3) bacteria exhibited mild non-specific signs of illness and were culture negative. One marmoset inoculated with 2.5 X 10(3) organisms developed moderate signs of disease and reached humane end-points 8 days post-infection. The liver and spleen of this animal were colonized with the agent and pathological analysis of tissues showed nasal, splenic and hepatic lesions. Taken together, these data indicate that the marmoset is a suitable model to study respiratory infection by B. mallei. |
format | Online Article Text |
id | pubmed-4393281 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43932812015-04-21 Use of the Common Marmoset to Study Burkholderia mallei Infection Jelesijevic, Tomislav Zimmerman, Shawn M. Harvey, Stephen B. Mead, Daniel G. Shaffer, Teresa L. Estes, D. Mark Michel, Frank Quinn, Frederick D. Hogan, Robert J. Lafontaine, Eric R. PLoS One Research Article Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, and the most common manifestations are life-threatening pneumonia and bacteremia. Glanders is difficult to diagnose and requires prolonged antibiotic therapy with low success rates. There is no vaccine to protect against B. mallei and there is concern regarding its use as a biothreat agent. Thus, experiments were performed to establish a non-human primate model of intranasal infection to study the organism and develop countermeasures. Groups of marmosets (Callithrix jacchus) were inoculated intranasally with B. mallei strain ATCC 23344 and monitored for clinical signs of illness for up to 13 days. We discovered that 83% of marmosets inoculated with doses of 2.5 X 10(4) to 2.5 X 10(5) bacteria developed acute lethal infection within 3–4 days. Signs of disease were severe and included lethargy, inappetence, conjunctivitis, mucopurulent and hemorrhagic nasal discharges, and increased respiratory effort with abdominal lifts. Burkholderia mallei was cultured from the lungs, spleen and liver of these animals, and pathologic examination of tissues revealed lesions characteristic of glanders. Challenge experiments also revealed that 91% of animals infected with doses ranging from 25 to 2.5 X 10(3) bacteria exhibited mild non-specific signs of illness and were culture negative. One marmoset inoculated with 2.5 X 10(3) organisms developed moderate signs of disease and reached humane end-points 8 days post-infection. The liver and spleen of this animal were colonized with the agent and pathological analysis of tissues showed nasal, splenic and hepatic lesions. Taken together, these data indicate that the marmoset is a suitable model to study respiratory infection by B. mallei. Public Library of Science 2015-04-10 /pmc/articles/PMC4393281/ /pubmed/25860021 http://dx.doi.org/10.1371/journal.pone.0124181 Text en © 2015 Jelesijevic et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Jelesijevic, Tomislav Zimmerman, Shawn M. Harvey, Stephen B. Mead, Daniel G. Shaffer, Teresa L. Estes, D. Mark Michel, Frank Quinn, Frederick D. Hogan, Robert J. Lafontaine, Eric R. Use of the Common Marmoset to Study Burkholderia mallei Infection |
title | Use of the Common Marmoset to Study Burkholderia mallei Infection |
title_full | Use of the Common Marmoset to Study Burkholderia mallei Infection |
title_fullStr | Use of the Common Marmoset to Study Burkholderia mallei Infection |
title_full_unstemmed | Use of the Common Marmoset to Study Burkholderia mallei Infection |
title_short | Use of the Common Marmoset to Study Burkholderia mallei Infection |
title_sort | use of the common marmoset to study burkholderia mallei infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393281/ https://www.ncbi.nlm.nih.gov/pubmed/25860021 http://dx.doi.org/10.1371/journal.pone.0124181 |
work_keys_str_mv | AT jelesijevictomislav useofthecommonmarmosettostudyburkholderiamalleiinfection AT zimmermanshawnm useofthecommonmarmosettostudyburkholderiamalleiinfection AT harveystephenb useofthecommonmarmosettostudyburkholderiamalleiinfection AT meaddanielg useofthecommonmarmosettostudyburkholderiamalleiinfection AT shafferteresal useofthecommonmarmosettostudyburkholderiamalleiinfection AT estesdmark useofthecommonmarmosettostudyburkholderiamalleiinfection AT michelfrank useofthecommonmarmosettostudyburkholderiamalleiinfection AT quinnfrederickd useofthecommonmarmosettostudyburkholderiamalleiinfection AT hoganrobertj useofthecommonmarmosettostudyburkholderiamalleiinfection AT lafontaineericr useofthecommonmarmosettostudyburkholderiamalleiinfection |